U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H14N2S
Molecular Weight 230.329
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METIZOLINE

SMILES

CC1=C(CC2=NCCN2)C3=C(S1)C=CC=C3

InChI

InChIKey=NDNKHWUXXOFHTD-UHFFFAOYSA-N
InChI=1S/C13H14N2S/c1-9-11(8-13-14-6-7-15-13)10-4-2-3-5-12(10)16-9/h2-5H,6-8H2,1H3,(H,14,15)

HIDE SMILES / InChI

Description

Metizoline is an adrenergic agent with vasoconstrictor properties. It has been used as the active component of nasal decongestant spray (Ellsyl).

Approval Year

Unknown
149124
Patents

Patents

JP2007508914A
18
Name Type Language
METIZOLINE
INN   MI   WHO-DD  
INN  
Official Name English
metizoline [INN]
Preferred Name English
METYZOLINE
Common Name English
METIZOLINE [MI]
Common Name English
2-((2-METHYLBENZO(B)THIEN-3-YL)METHYL)-2-IMIDAZOLINE
Systematic Name English
METIZOLINE [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC R01AA10
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
WHO-VATC QR01AA10
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
NCI_THESAURUS C29709
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
Code System Code Type Description
MERCK INDEX
m347
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY Merck Index
CHEBI
81951
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
EPA CompTox
DTXSID9074983
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
INN
2380
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
PUBCHEM
28688
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
EVMPD
SUB08898MIG
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
FDA UNII
Z27L8N105U
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
ChEMBL
CHEMBL1370446
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
CAS
17692-22-7
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
MESH
C010242
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
DRUG BANK
DB13614
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
DRUG CENTRAL
4671
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
WIKIPEDIA
METIZOLINE
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
SMS_ID
100000080936
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
NCI_THESAURUS
C99577
Created by admin on Wed Apr 02 07:55:36 GMT 2025 , Edited by admin on Wed Apr 02 07:55:36 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of METIZOLINE
SALT/SOLVATE (PARENT)
Structure of METIZOLINE HYDROCHLORIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966